Biosynex SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 382.5 million compared to EUR 153.9 million a year ago. Net income was EUR 104 million compared to EUR 31.4 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 EUR | -0.95% | +13.26% | -37.60% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.60% | 60.25M | |
+1.49% | 12.66B | |
-17.03% | 7.04B | |
+1.73% | 4.32B | |
-2.51% | 4.45B | |
-50.32% | 3.31B | |
+6.90% | 2.6B | |
-16.90% | 2.01B | |
-3.40% | 1.67B | |
-6.24% | 1.45B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2021